You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment

Article Text

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Cellular therapies
145 Preclinical development of EDIT-201, a multiplexed CRISPR-Cas12a gene edited healthy donor derived NK cells demonstrating improved persistence and resistance to the tumor microenvironment

https://doi.org/10.1136/jitc-2020-SITC2020.0145

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.